Paris, France and Camberley, UK – 30 April 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its audited financial results for the year ended 31 December 2018 and restated financial results for the year ended 31 December 2017 following the impact of the discontinuing operations of NOVAprep®.
Visit PageCategory: Board
Mise à jour sur la publication des résultats annuels
Paris, France et Camberley, UK – 25 avril 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), spécialiste international du diagnostic clinique, annonce qu’il prévoit désormais de publier ses résultats audités pour l’exercice clos le 31 décembre 2018, le 30 avril 2019. http://novacyt.com/wp-content/uploads/2019/04/Novacyt-Mise-à-jour-sur-la-publication-des-résultats-annuels.pdf
Visit PageUpdate on Notice of Full Year Results
Paris, France and Camberley, UK – 25 April 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it now intends to report its audited results for the full year ended 31 December 2018, on 30 April 2019. http://novacyt.com/wp-content/uploads/2019/04/Novacyt-update-on-notice-of-FY-results.pdf
Visit Page